- Despite returning to topline growth, The Limners and Bards Limited (LAB) recorded a net loss for the third quarter ended July 31, 2026. The result extended the volatility in LAB’s earnings performance, with the company moving from a loss in Q1 to a profit in Q2 before slipping back into a loss in Q3. A greater contribution from the lower-margin Media segment, higher production costs and increased film-distribution expenses resulted in the net loss of J$4.68Mn, compared with a net profit of J$21.66Mn in Q3 2025.
- Revenues increased 5.1% year-over-year (YoY) to J$280.71Mn, from J$267.14Mn, supported primarily by the Media segment. However, the cost of generating revenue rose considerably faster, increasing 22.0% to J$201.73Mn. Consequently, gross profit declined 22.4% to J$78.98Mn, while the gross margin contracted by 10.0 percentage points to 28.1%.
- Administrative expenses declined 10.8% YoY to J$69.77Mn, reflecting continued cost-control measures. However, this was more than offset by selling and distribution expenses, which increased to J$15.50Mn from J$1.04Mn, primarily reflecting marketing and distribution expenditure associated with LAB Studios’ first slate of films. As a result, total administrative, selling and distribution expenses increased 7.6% to J$85.27Mn, further pressuring the quarter’s earnings.
- Despite the improvement in third quarter revenue, LAB’s nine-month performance remained considerably weaker. Revenue declined 15.0% YoY to J$618.49Mn, while gross profit fell 25.9% to J$205.40Mn. This contributed to a nine-month net loss of J$18.17Mn, reversing the net profit of J$42.26Mn recorded in the corresponding period of 2025.
- Media remained LAB’s largest business line, contributing J$322.14Mn, or 52.1%, of nine-month revenue. However, the segment generated a gross margin of only 16.6%, compared with 41.8% for Production and 68.8% for Agency. Therefore, a sustained recovery in consolidated earnings will depend not only on revenue growth but also on LAB securing more Production and Agency work or improving the margins earned on its Media contracts.
- Looking ahead, LAB’s near-term priority will be to sustain the recent revenue recovery and shift its sales mix toward higher-margin services. Management expects FY2027 to mark a transition from investing in its film and artificial-intelligence platforms to monetising these initiatives. However, the timing and scale of the resulting earnings remain uncertain, with a return to profitability dependent on successful film distribution, audience uptake, commercial demand for its AI-enabled services and disciplined control of related distribution expenditure. Shareholders will therefore require clearer evidence that these investments in content creation that started around 4 to 5 years ago can generate stronger margins and positive operating cash flow.
- At the close of trading on September 16, 2026, LAB’s share price was J$1.00, representing a 3.8% decline year-to-date. At this price, the stock trades at a price-to-book ratio of approximately 1.5x, slightly below the Junior Market Other Sector average of 1.6x.
(Sources: JSE, NCBCM Research)
